My Heart Will Go On: Management of calcium channel blocker and beta blocker toxicity
My Heart Will Go On: Management of calcium channel blocker and beta blocker toxicity
Schedule: October 21, 2021, 2:30 to 3:30pm Live Virtual, Boston, MA
Audience: Accredited for Pharmacists and Technicians
Other interested health care professionals welcome
Credits: 1 Contact Hour of knowledge-based 1.0 CEUs will be awarded under the provider
Presenter: Clare Cycz, Pharm.D., PGY2 Critical Care Pharmacy Resident Beth Israel Deaconess Medical Center
No charge for CE
Learning Objectives for Pharmacists:
0837-9999-21-187-L01-P
After attending this program, participants will be able to:
- Describe the pharmacokinetics and to toxicokinetics associated with beta blockers and calcium channel blockers
- Identify interventions for beta blocker and/or calcium channel blocker toxicity and highlight those that have shown to improve mortality
- Discuss the use of high dose insulin euglycemic therapy for a patient with beta blocker and/or calcium channel blocker toxicity
Learning Objectives for Technicians:
0837-9999-21-188-L01-T
- Identify medications associated with mortality benefit in CCB/BB overdose
- Express the importance of timely medication compounding and delivery for patients with CCB/BB overdose
- Review sterile compounding methods/guidelines for glucagon and high dose insulin therapy
Requirements for Receiving CE Credit:
- Successful completion of post presentation questions
- Participation at live program
- Complete program online evaluation form
- NABP #